Abstract 6867: Triplet combination of monzosertib, a potent CDC7 inhibitor, with DNMT and BCL2 inhibitors is highly active in human AML xenograft mouse models

Authors: Hatsuo Furuichi, Hiroko Endo, Akinori Arimura, Yu Nishioka, Masaaki Sawa

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-6867

Source: Full article